GSK’s hepatitis B treatment yields positive data in Phase IIa trial
GSK will virtually present the data at The Digital International Liver Congress (ILC) 2020. Credit: GSK.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more